GLOW (TB-500 + BPC-157 + GHK-Cu)
Lyophilized research reference material. Released with a per-lot Certificate of Analysis. For laboratory research use only.
- All products currently listed on this site are for research purposes ONLY.
- All products sold on this website are intended for research and identification purposes only.
- These products are not intended for human dosing, injections, or ingestion.
- Peptides are strictly for laboratory, academic, or institutional research and not for human or animal consumption.
Research background
GLOW (also designated BBG70) is a research blend that commonly combines BPC-157, TB-500, and the copper tripeptide GHK-Cu. The rationale studied in the literature is convergence of complementary repair-associated pathways: angiogenesis and growth-factor signaling (BPC-157), actin regulation and cell migration (TB-500), and matrix remodeling (GHK-Cu).
No controlled studies characterize this specific combination; supporting evidence consists of separate preclinical work on each component.
Summary of published scientific literature provided for laboratory research reference only. It is not a claim of safety, efficacy, or suitability for any use, and does not describe or recommend any human or veterinary use.
Selected references
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide. International Journal of Molecular Sciences. 2018;19(7):1987.
- Sikiric P, et al. Brain-gut axis and pentadecapeptide BPC 157. Current Neuropharmacology. 2016;14(8):857-865.
- Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine. 2005;11(9):421-429.
Trademarks & attribution
GLOW (BBG70) is a research blend; its component compounds (BPC-157, TB-500, GHK-Cu) are investigational or non-trademark-restricted. Catalyst Research Labs is not affiliated with any branded product. Supplied as reference material only.
-
PeptidesRESEARCH USE ONLY COA 2–8°C
